Search
Showing results for "clinical trials"
This review article examines the evidence of the impact of in utero and postnatal vitamin D exposure on allergy risk in childhood
Invasive pneumococcal disease (IPD) continues to occur at high rates among Australian Aboriginal people.
Influenza is major cause of paediatric hospitalisation. Influenza vaccine was offered to all children aged 6-59 months resident in Western Australia in 2008
In Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4 and 6 months of age, with no booster dose.
Acute lower respiratory infections (ALRI) are a major cause of hospitalisation in young children
Diarrhoeal disease is the second leading cause of death in children under 5 years globally, killing 525 000 annually. Australian Aboriginal and Torres Strait Islander (hereafter Aboriginal) children suffer a high burden of disease.
STAMP RSV is a multifaceted program of work with the single focus to prepare the community for the uptake of new and emerging RSV immunisation strategies by providing the evidence to inform public health policy.
With the help of clinicians and families who have children with Rett syndrome, our research aims to improve understanding of Rett syndrome.
Our aim is for all kids to have healthy skin. We work with communities to reduce the burden of Strep A skin sores and sore throats to prevent rheumatic fever.
Elevated antimicrobial proteins and peptides and cytokines in middle ear effusion are a marker of inflammation and bacterial persistence